The genome-wide analysis by Ellis et al. identified differential DNA methylation of promoter regions in peripheral blood CD4+ T cells from methotrexate-naïve JIA patients, compared to healthy controls, and found that reduced methylation at IL32 was associated with JIA [123]. The gene discussed is CD4; the disease is juvenile idiopathic arthritis.